Page 8 - Penn Memory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Holiday family gatherings can be challenging under the best of circumstances.

Jul 12, 2021 As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer’s disease approved in 18 years, patients want to know: “Will this medication help me — and how much?” Doctors explaining the pros and cons of Aduhelm won’t have a definitive answer. “On an individual basis, it will be absolutely impossible to predict,” said Dr. Allan Levey, director of the Goizueta Alzheimer’s Disease Research Center at Emory University. Cognitive decline varies widely among people who have started experiencing memory and thinking problems or wh...

Matt York/AP toggle caption Matt York/AP Dr. William Burke reviews a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018. An experimental Alzheimer's drug from Biogen and Eisai is on the verge of a Food and Drug Administration decision. Matt York/AP A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease rather than relieve symptoms. But it's unclear whether the Food and Drug Administration will approve the drug because of persistent questions about its effectiveness. The FDA h...

The FDA has until Monday to decide whether to approve the first new Alzheimer's drug in nearly two decades. Two big studies of the drug produced conflicting results.

The problem of Alzheimer’s: Caregiver exhaustion and a minefield of ethical quandaries As the world's population ages, a new generation will be facing Alzheimer's. A new book delves into the disease's toll and what's needed to quell the effects of the coming wave. (Getty Images) It’s hard to find good news about Alzheimer’s disease. The dementia math has been pitiless for decades, especially as it applies to Alzheimer’s, which accounts for up to three-quarters of dementia cases. All over the developed world, elderly populations continue to grow as percentages of their national total...